Schedule 13G ownership disclosure

XERIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 98422L107

Event date: 2020-02-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001398344-20-003916
Form type
SC 13G
Filer
Sessa Capital (Master), L.P.
CIK
CIK 1618360
Filed
Feb 21, 2020
Reporting period
Feb 12, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub